Unitaid and RIGHT Foundation partner to accelerate access to health innovations for low- and middle-income countries

Developing child-friendly TB medicines

More tolerable treatments for drug-resistant TB

Expanded, shortened treatment options are now recommended for all populations with multidrug-resistant tuberculosis (MDR-TB).

Shorter TB prevention regimens (3HP/1HP)

Medicines that clear TB infection from a person’s system before it develops into active disease. 

TB medicines for children

Fruit-flavored, properly dosed medicines for preventing and treating all forms of tuberculosis (TB) in children.  

Diagnostic sequencing for tuberculosis

A novel class of diagnostic technology that can quickly identify resistance to multiple tuberculosis (TB) drugs and determine which drugs are likely to work best. 

WHO recommendations, supported by Unitaid clinical trials, now allow for better treatment for all people with drug-resistant TB, including children and pregnant women

Global Fund and Unitaid increase collaboration to advance equitable access to health products